Radiobiology of LDR, HDR, PDR and VLDR Brachytherapy - GEC-ESTRO Handbook of Brachytherapy

Radiobiology of LDR, HDR, PDR and VLDR Brachytherapy

18

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part I: The Basics of Brachytherapy Version 1 - 22/10/2015

12. REFERENCES

25. Dörr,W. :Time factors in normal tissue responses to irradiation in: Joiner, M., Van der Kogel, A. (Eds.) Basic Clinical Radiobiology, 4th Edition, Chapter 11; Hodder Arnold, London, 2009, 149-157 26. Dörr, W.Modulation of repopulation processes in oral mucosa: experimental results Int. J. Radiat. Biol. 79, 2003, 531-537 27. Dörr, W.Three A’s of repopulation during fractionated irradiation in squa- mous epithelia: Asymmetry loss, Acceleration of stem-cell divisions and abor- tivedivisions. Int. J. Radiat. Biol. 72, 1997, 635-643 28. Dörr,W.The radiobiology of tissue reactions Ann. ICRP 44, 1 Suppl., 2015, 58- 68 29. Dörr,W.,Schmidt,M.:Normal tissue radiobiology In: Brahme, A. (Ed.-in- Chief), Hendry, J. H. (Vol. Ed.): Comprehensive biomedical physics. Vol. 7, Chapter 7.05, Elsevier, Amsterdam-Oxford-Waltham, 2014, 75-95 30. Dubray B, Mazeron JJ, Simon JM, et al . Time factors in breast carcinoma: influence of delay between external irradiation and radiotherapy. Radiother Oncol 1992; 25: 267-72. 31. Finestres-Zubeldia F, Guix Melcior B, Cloquell Damián A, et al . Treatment of the carcinoma of the lip through high dose rate BT. Med Oral Patol Oral Cir Bucal 2005; 10: 17-24 32. Fontanesi MD, Hetzler D, Ross J. Effects of dose rate on local control and com- plications in the re-irradiation of the head and neck tumors. Int J Radiat Oncol Biol Phys 1989; b: 365-9. 33. Fourquet A, Campana F, Mosseri V, et al . Iridium -192 versus cobalt -60 boost in breast treated by irradiation alone: final results of a randomized trial. Radioth- er Oncol 1995; 34: 114-20. 34. Fowler JF, Toma-Dasu I, Dasu A Is the α/β ratio for prostate tumours really low and does it vary with the level of risk at diagnosis? Anticancer Res. 2013 Mar;33(3):1009-11 35. Fowler JF, Mount M. Pulsed BT: the conditions for no significant loss of ther- apeutic ratio compared with traditional low dose rate BT. Int J Radiat Oncol Biol Phys 1992; 23: 661-9. 36. Fowler JF. Why shorter half-times of repair lead to greater damage in pulsed BT. Int J Radiat Oncol Biol Phys 1993; 26: 353-56. 37. Fowler JF. Are half-times of repair reliably shorter for tumors than for late normal-tissue effects? Int J Radiat Oncol Biol Phys 1995; 31: 189-90. 38. Fowler JF, Van Limbergen E. Biological effect of pulsed dose rate BT with step- ping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 1997; 37: 877-83. 39. Fritz P, Berns C, Anton HW et al . PDR BT with flexible implants for intestinal boost after breast-conserving surgery and external beam radiation therapy. Radiother Oncol 1997; 45: 23-32. 40. Fritz P, Hensley FW, Berns C et al . Long-term results of pulsed irradiation of skin metastases from breast cancer. Effectiveness and sequel. Strahlenther Onkol 2000; 176: 368-376. 41. Fu KK, Phillips TL. High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1990; 19(3):791-6. 42. Fu KK, Chan EK, Phillips TL, Ray JW. Time, dose and volume factors in inter- stitial radium implants of the oral tongue. Radiology 1976; 119: 209-13. 43. Galalae RM, Martinez A, Mate T, et al . Long-term outcome by risk factors us- ing conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys. 2 004 Mar 15;58(4):1048-55 44. Gérard JP, Mauro F, Thomas L, Castelain B ,Mazeron JJ, Ardiet JM,Peiffert D. Treatment of squamous cell anal canal carcinoma with pulsed dose rate BT. Feasibility study of a French Cooperative group. Radiother Oncol 1999; 51:129-31. 45. Girinsky T, Rey A, Roche B, Haie C, Gerbaulet A, Randrianarivello H, Chas- sagne D.Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome. Int J Radiat Oncol Biol Phys. 1993 Dec 1; 27(5):1051-6. 46. Guinot JL, Arribas L, Chus ML, et al . Lip cancer treatment with high dose rate BT. Radioth Onocl 2003; 69:113-115 47. Haie-Meder C, Kramar A, Lambin P, et al . Analysis of complications in a pro-

1. Ang KK, Van der Kogel AJ, Van der Schueren E. The kinetics of repair of sub- lethal damage in the rat cervical spinal cord during fractionated irradiation. Int J Radiat Oncol Biol Phys 1984; 11: 1977-83. 2. Armour EP, White JR, Armin A, et al . Pulsed low dose rate BT in a rat model: dependence of late rectal injury on radiation pulse size. Int J Radiat Oncol Biol Phys 1997; 38: 825-34. 3. Awwad HK, Burgers MV. Studies in dose-time volume relationships in blad- der and tongue radium implants. Clin Radiol 1976; 27: 443-8. 4. Bachtiary B, Dewitt A, Pintillie et al . Comparison of late toxicity between con- tinuous low-dose-rat and pulsed-dose –rate BT in cervical cancer patients. Int J Radiat Oncol Biol Phys 2005; 63: 1077-82. 5. Barendsen GW. Dose fractionation, dose rate and isoeffect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981-7. 6. 7. Barkley HY, Fletcher GH. Volume and time factor in interstitial gamma-ray therapy. Am J Roentgenol 1976; 126: 163-70. 8. Bedford JS, Hall EJ. Threshold hypoxia: Ist effect on the survival of mammali- an cells irradiated at high and low dose-rates. Br J Radiol 1966; 39: 896-900. 9. Benk V, Mazeron JJ, Grimard L, et al . Comparison of curietherapy versus ex- ternal irradiation in Stage II squamous cell carcinoma of the mobile tongue. Radiother Oncol 1990; 18: 339-47. 10. Bentzen SM, Thames HD. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 1991; 22: 161-6. 11. Bentzen, S. M., Dörr, W., Gahbauer, R., Howell, R. W., Joiner, M. C., Jones, B., Jones, D. T. L., Van der Kogel, A. J., Wambersie, A., Whitmore, G. Bioeffect modeling and equieffective dose concepts in radiation oncology Terminolo- gy,quantities and units. Radiother. Oncol ., 2012 105, 266-268 12. Brenner DJ, Hall EJ. Fractionated high dose rate versus low dose rate regimens for intracavitary technique of the cervix. Br J Radiol 1991; 64: 133-41. 13. Brenner DJ, Hall EJ. Conditions for the equivalence of continuous to pulsed low dose rate BT. Int J Radiat Oncol Biol Phys 1991; 20: 181-90. 14. Brenner DJ, Hall EJ, Huang Y, Sachs RK. Potential reduced late effects for pulsed BT compared with conventional LDR. Int J Radiat Oncol Biol Phys 1995; 31: 201-10. 15. Brenner DJ, Schiff PB, Huang Y, Hall EJ. Pulsed-dose-rate BT: design of con- venient (day-time only) schedules. Int J Radiat Oncol Biol Phys 1997; 39: 809- 15. 16. Bruna A, Gastelblum P, Thomas L et al . treatment of squamous cell anal canal carcinoma (SCACC) with pulsed dose rate BT: a retrospective study. Radioth Oncol 2006; 79: 75-79. 17. Cosset JM, Henry-Amar M,Girinsky T et al . late toxicity of radiotherapy in Hodgkin’s disease: the role of fraction size. Acta Oncol 1988; 27: 123 – 46 18. Cha C. M., Potters L., Ashley R., Freeman K., Wang X.-H., Waldbaum R.,Liebe S. l, ‘‘Isotope selection for patients undergoing prostatebrachytherapy,’’ Int. J. Radiat. Oncol, Biol., Phys. 45, 31–395 ~1999. 19. Dale RG. The applications of the linear-quadratic dose effect equation to frac- tionated and protracted therapy. Br J Radiol 1985; 58: 515-28. 20. Dale RG. Radiobiological assessment of permanent implants using tumour repopulation factors in the linear-quadratic model. Br J Radiol 1989; 62: 241-4. 21. Dale RG, Jones B, Coles IP. Effect of tumour shrinkage on the biological effec- tiveness of permanent BT implants. Br J Radiol 1994; 67: 639-45. 22. De Pree C, Popowski Y,Weber D.Nouet P, Rouzaud M, Kurtz JM. Feasibility and tolerance of pulsed dose rate interstitial BT. Int J Radiat Oncol Biol Phys 1999; 43: 971-6. 23. Donath D, Vuong T, Shenouda G, MacDonald B, Tabah R. The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer. Eur Arch Otorhinolaryngol. 1995;252:321–324. 24. Dörr,W.,Van der Kogel,A.J.The volume effect in radiotherapy in: Joiner, M., Van der Kogel, A. (Eds.) Basic Clinical Radiobiology, 4th Edition, Chapter 14; Hodder Arnold, London, 2009; 191-206